PSA Test as a Prognostic Indicator in Breast Cancer
Author Information
Author(s): S Lehrer, M Terk, SP Piccoli, HK Song, P Lavagnini, AA Luderer
Primary Institution: Mount Sinai Medical Center
Hypothesis
Can reverse transcriptase-polymerase chain reaction (RT-PCR) for prostate-specific antigen (PSA) serve as a prognostic indicator in women with node-negative breast cancer?
Conclusion
PSA RT-PCR may help identify women with node-negative breast cancer who are at risk of recurrence and could benefit from adjuvant therapy.
Supporting Evidence
- Approximately 30% of breast cancer cells produce PSA.
- PSA RT-PCR detected the amplified PSA fragment in 18 of 78 women with breast cancer.
- 7 of the 18 women with the PSA fragment had localized, small, node-negative tumors.
Takeaway
This study looked at a blood test that can find cancer cells in women with breast cancer, helping doctors know who might need extra treatment.
Methodology
The study evaluated blood samples from 78 women with confirmed breast cancer using RT-PCR to detect PSA.
Limitations
The study is preliminary and the sample size is relatively small.
Participant Demographics
The mean age of participants was 59 years, with ages ranging from 31 to 94.
Want to read the original?
Access the complete publication on the publisher's website